Endocrinology, Vol 134, 2445-2452, Copyright © 1994 by Endocrine Society

ARTICLES

Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts

A Zapf, D Hsu and JM Olefsky
Department of Medicine, University of California-San Diego School of Medicine, La Jolla 92093.

In this study we have compared the intracellular itineraries of insulin and insulin-like growth factor-I (IGF-I) and their receptors subsequent to ligand internalization in rat fibroblasts. We found that the endocytic rate constant is approximately 3 times as high for insulin as for IGF-I. The dissociation of internalized ligand from its receptor was monitored by the ability of ligand-receptor complexes to precipitate in the presence of polyethylene glycol (PEG). Insulin loses its ability to precipitate with PEG more rapidly than IGF-I. After 60 min, less than 10% of the intracellular insulin remains PEG precipitable, whereas 44% of intracellular IGF-I stays PEG precipitable. Ligand degradation was determined by precipitation with trichloroacetic acid (TCA). Insulin degradation after internalization is more rapid compared with IGF-I degradation; after 2 h, 80% of intracellular IGF-I, in contrast to only 30% of intracellular insulin, remains intact. We measured retroendocytosis of insulin and IGF-I by assessing the amount of internalized ligand that was subsequently released from the cells. When analyzing released ligand by TCA precipitation, we found that 25% of insulin and 53% of IGF-I were TCA precipitable. After 120 min, only 16% of insulin and 43% of IGF-I remained intracellular. To provide insight into a possible mechanism that prevents IGF-I from being subjected to the same degree of degradation as insulin, we studied the effect of pH on IGF-I and insulin binding. We found IGF-I binding to be less sensitive to decreases in pH compared with insulin binding. Therefore, it is likely that after internalization, IGF-I does not dissociate from its intracellular receptor as easily as insulin in the acidifying endosome and, therefore, can return to the cell surface via a recycling receptor. In summary, we have observed distinct differences in the intracellular itineraries of IGF-I and insulin and their receptors. IGF- I internalization and degradation proceed less efficiently than insulin internalization, and IGF-I is preferentially targeted into a retroendocytotic pathway in contrast to insulin, which primarily undergoes lysosomal degradation. The differential effect of pH on ligand binding to these structurally related hormone receptors may account for the quantitatively distinct ligand trafficking events.

This article has been cited by other articles:

				R. J. Romanelli, A. P. LeBeau, C. G. Fulmer, D. A. Lazzarino, A. Hochberg, and T. L. Wood Insulin-like Growth Factor Type-I Receptor Internalization and Recycling Mediate the Sustained Phosphorylation of Akt J. Biol. Chem., August 3, 2007; 282(31): 22513 - 22524. [Abstract] [Full Text] [PDF]

				C. Biedi, D. Panetta, D. Segat, R. Cordera, and D. Maggi Specificity of Insulin-Like Growth Factor I and Insulin on Shc Phosphorylation and Grb2 Recruitment in Caveolae Endocrinology, December 1, 2003; 144(12): 5497 - 5503. [Abstract] [Full Text] [PDF]

				D. Sachdev, S.-L. Li, J. S. Hartell, Y. Fujita-Yamaguchi, J. S. Miller, and D. Yee A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I Cancer Res., February 1, 2003; 63(3): 627 - 635. [Abstract] [Full Text] [PDF]

				C. Mulligan, J. Rochford, G. Denyer, R. Stephens, G. Yeo, T. Freeman, K. Siddle, and S. O'Rahilly Microarray Analysis of Insulin and Insulin-like Growth Factor-1 (IGF-1) Receptor Signaling Reveals the Selective Up-regulation of the Mitogen Heparin-binding EGF-like Growth Factor by IGF-1 J. Biol. Chem., November 1, 2002; 277(45): 42480 - 42487. [Abstract] [Full Text] [PDF]

				R. D. York, D. C. Molliver, S. S. Grewal, P. E. Stenberg, E. W. McCleskey, and P. J. S. Stork Role of Phosphoinositide 3-Kinase and Endocytosis in Nerve Growth Factor-Induced Extracellular Signal-Regulated Kinase Activation via Ras and Rap1 Mol. Cell. Biol., November 1, 2000; 20(21): 8069 - 8083. [Abstract] [Full Text]

				B. Urso, D. L. Cope, H. E. Kalloo-Hosein, A. C. Hayward, J. P. Whitehead, S. O'Rahilly, and K. Siddle Differences in Signaling Properties of the Cytoplasmic Domains of the Insulin Receptor and Insulin-like Growth Factor Receptor in 3T3-L1 Adipocytes J. Biol. Chem., October 22, 1999; 274(43): 30864 - 30873. [Abstract] [Full Text] [PDF]

				A. Santhanagopal and S. J. Dixon Insulin-like growth factor I rapidly enhances acid efflux from osteoblastic cells Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E423 - E432. [Abstract] [Full Text] [PDF]

				A. Zapf-Colby and J. M. Olefsky Nerve Growth Factor Processing and Trafficking Events Following TrkA-Mediated Endocytosis Endocrinology, July 1, 1998; 139(7): 3232 - 3240. [Abstract] [Full Text] [PDF]

				C. R. Haft, M. de La Luz Sierra, I. Hamer, J.-L. Carpentier, and S. I. Taylor Analysis of the Juxtamembrane Dileucine Motif in the Insulin Receptor Endocrinology, April 1, 1998; 139(4): 1618 - 1629. [Abstract] [Full Text] [PDF]

				S. L. Calzi, C. V. Choice, and S. M. Najjar Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E801 - E808. [Abstract] [Full Text] [PDF]

				D. R. Ure and R. B. Campenot Retrograde Transport and Steady-State Distribution of 125I-Nerve Growth Factor in Rat Sympathetic Neurons in Compartmented Cultures J. Neurosci., February 15, 1997; 17(4): 1282 - 1290. [Abstract] [Full Text] [PDF]